about
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system.BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.Mycobacterium.Cytotoxic activity of Mycobacterium ulcerans.Histopathologic features of Mycobacterium ulcerans infection.Surgical management of buruli ulcer disease: a four-year experience from four endemic districts in ghana.Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010.Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infectionSurgical pathology in the course of the Nile.Corynebacterium diphtheriae in skin lesions in Ugandan children.Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection.History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease).PEDIATRICS IN UGANDA.The increasing interest in microbial skin disease.In vitro susceptibility of Mycobacterium ulcerans to clarithromycinThe chemistry and biology of mycolactones.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.Buruli ulcer. Review of a neglected skin mycobacterial disease.The Use of Surgery and Local Temperature Elevation in Mycobacterium Ulcerans Infection.Buruli ulcer in the Democratic Republic of Congo: epidemiology, presentation and outcome.Ulcer due to Mycobacterium ulcerans in Northern Ireland.Epidemiology of Mycobacterium ulcerans infection (buruli ulcer) at Kinyara, UgandaUnderstanding perceptions on 'Buruli' in northwestern Uganda: A biosocial investigationClinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection). Report II of the Uganda Buruli Group
P2860
Q24186073-CE0F9279-79BC-42D3-AEED-4C188E1F815AQ33688534-CD5D7800-CB7C-4334-B019-F43B20772941Q33851427-DC56B8C9-05BD-4615-9707-0B7C06CD42AEQ34016179-83655BF7-A892-4ACB-BB9C-5E00C642DA5FQ34033119-153689F4-593C-4F57-8A7B-416A142EB1F1Q34072948-86C0B4EB-234F-472A-A308-762384C26511Q34109878-A0A2931D-76E2-453C-A508-B56743C9FA15Q34396322-41A50A46-C1A2-46F1-AE77-0D606296E16FQ34954144-5B98315F-C83B-4357-B695-8FD0AF5948E7Q35530457-3AA6AA78-6A83-4CFB-BFC8-4A8C8687A02AQ35625819-43CC2EA7-CD16-4F46-9ADE-6E5B72EA407EQ35689228-8FDE4D3C-EECB-4F69-9841-7B59C6B81DF0Q35949741-242E96EA-EB6E-4801-9669-0D4A4A969B0CQ36559291-E9AD44F7-8683-47F2-B9E4-49FA0E1763D4Q36720331-A1AC7D2A-FBC7-4A6E-BD1C-537510788166Q38001023-585A1C3D-321D-4CA3-A398-E7E88CD0FC14Q38157768-276E5B1F-14E5-4217-9C54-6DB0207D25B8Q38898143-C0E74FB5-1E66-48CB-83EE-2CD8525554C2Q39307388-04667146-8C06-4247-AEE3-5933D0D9B2A5Q39364483-DF658E78-4285-459C-9FC1-BCCBD684437CQ41469222-269C8F36-076A-4FC0-A8EF-42E2D56428A8Q46241939-4AC083F5-CB52-47C3-837F-B6BBA6B2A844Q49990263-FE5C7734-508B-4805-B041-97EB3327C899Q50105218-4EDFD871-22C3-461B-8A19-9E2BA7CEFA89Q54125828-DCB50FD8-8163-4024-840C-94DCD0E2DD96Q54160024-422B61E5-2EEC-4526-B38F-552FD1F4935CQ56455443-280A6576-5964-4B59-B4BA-F0C9148B6A1BQ56911060-C90C3D65-D995-406A-8279-A65254E55154Q56923002-334356D3-5DB9-4D0C-864C-3CB6451AAE18
P2860
description
1961 nî lūn-bûn
@nan
1961年の論文
@ja
1961年学术文章
@wuu
1961年学术文章
@zh-cn
1961年学术文章
@zh-hans
1961年学术文章
@zh-my
1961年学术文章
@zh-sg
1961年學術文章
@yue
1961年學術文章
@zh
1961年學術文章
@zh-hant
name
Mycobacterial skin ulcers in Uganda.
@en
type
label
Mycobacterial skin ulcers in Uganda.
@en
prefLabel
Mycobacterial skin ulcers in Uganda.
@en
P2093
P1433
P1476
Mycobacterial skin ulcers in Uganda.
@en
P2093
P304
P356
10.1016/S0140-6736(61)90793-0
P407
P577
1961-10-01T00:00:00Z